AMLODIPINE AND OLMESARTAN MEDOXOMIL

AMLODIPINE AND OLMESARTAN MEDOXOMIL was reported 204 times

AMLODIPINE AND OLMESARTAN MEDOXOMIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ACQUIRED C1 INHIBITOR DEFICIENCY 1 0.0476
1 CONFABULATION 2 0.0075
2 SALPINGO-OOPHORECTOMY BILATERAL 1 0.0050
3 FAMILIAL PERIODIC PARALYSIS 1 0.0044
4 NECROTISING OESOPHAGITIS 2 0.0040
5 VASCULAR ENCEPHALOPATHY 1 0.0035
6 FALSE NEGATIVE INVESTIGATION RESULT 2 0.0028
7 ORAL DISCHARGE 1 0.0027
8 ANGIODYSPLASIA 1 0.0027
9 ACCELERATED HYPERTENSION 1 0.0026
10 MANUFACTURING MATERIALS ISSUE 1 0.0025
11 SPRUE-LIKE ENTEROPATHY 12 0.0024
12 SWEAT GLAND DISORDER 1 0.0024
13 SYSTOLIC HYPERTENSION 1 0.0023
14 JOINT SURGERY 1 0.0023
15 SINUS RHYTHM 1 0.0023
16 DISTRIBUTIVE SHOCK 5 0.0022
17 BEZOAR 3 0.0022
18 GALLBLADDER RUPTURE 1 0.0022
19 POST PROCEDURAL DIARRHOEA 1 0.0020
20 KELOID SCAR 1 0.0019
21 INTESTINAL ANASTOMOSIS 1 0.0016
22 PROCEDURAL VOMITING 1 0.0015
23 ELECTROCARDIOGRAM T WAVE ABNORMAL 2 0.0013
24 PROCEDURAL NAUSEA 1 0.0012
25 VASOPLEGIA SYNDROME 2 0.0012
26 COLITIS MICROSCOPIC 5 0.0011
27 SMALL INTESTINAL STENOSIS 1 0.0009
28 PRURITUS ALLERGIC 1 0.0009
29 GROIN ABSCESS 1 0.0008
30 NASAL PRURITUS 1 0.0008
31 BLOOD SODIUM INCREASED 2 0.0007
32 CLONUS 2 0.0007
33 ISCHAEMIC HEPATITIS 1 0.0007
34 NODAL RHYTHM 1 0.0007
35 NORMOCYTIC ANAEMIA 1 0.0007
36 GINGIVAL HYPERTROPHY 1 0.0007
37 HYPERTROPHIC CARDIOMYOPATHY 1 0.0006
38 RECALLED PRODUCT ADMINISTERED 6 0.0006
39 NASAL ULCER 1 0.0006
40 RESPIRATORY ALKALOSIS 1 0.0006
41 MEDICAL PROCEDURE 1 0.0006
42 AORTIC VALVE STENOSIS 1 0.0006
43 CAROTID ARTERY OCCLUSION 2 0.0005
44 ACUTE PULMONARY OEDEMA 3 0.0005
45 OESOPHAGEAL ULCER 2 0.0005
46 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
47 CHOLESTATIC LIVER INJURY 1 0.0004
48 COLITIS ISCHAEMIC 3 0.0004
49 DISCOURAGEMENT 1 0.0004
50 ACUTE PSYCHOSIS 1 0.0004
51 PRODUCT ODOUR ABNORMAL 4 0.0004
52 NYSTAGMUS 2 0.0004
53 LARGE INTESTINAL ULCER 1 0.0004
54 CLUMSINESS 1 0.0004
55 SEROTONIN SYNDROME 7 0.0004
56 OESOPHAGEAL STENOSIS 1 0.0004
57 HEART VALVE INCOMPETENCE 1 0.0003
58 DYSPNOEA AT REST 1 0.0003
59 THORACIC VERTEBRAL FRACTURE 1 0.0003
60 ABDOMINAL ADHESIONS 1 0.0003
61 HYPOVENTILATION 1 0.0003
62 SUPRAVENTRICULAR EXTRASYSTOLES 1 0.0003
63 NEOPLASM RECURRENCE 1 0.0003
64 KETOACIDOSIS 2 0.0003
65 OESOPHAGEAL DISORDER 1 0.0003
66 REHABILITATION THERAPY 1 0.0003
67 RESPIRATORY ACIDOSIS 1 0.0003
68 AZOTAEMIA 1 0.0003
69 TRIGEMINAL NEURALGIA 1 0.0002
70 LIP OEDEMA 1 0.0002
71 TONGUE DISCOMFORT 1 0.0002
72 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
73 CARDIAC OPERATION 2 0.0002
74 METABOLIC ACIDOSIS 7 0.0002
75 HYPOKALAEMIA 10 0.0002
76 PANCREATIC DISORDER 1 0.0002
77 BREATH SOUNDS ABNORMAL 1 0.0002
78 ABDOMINAL TENDERNESS 1 0.0002
79 BASAL CELL CARCINOMA 3 0.0002
80 MALABSORPTION 1 0.0002
81 OVERWEIGHT 1 0.0002
82 INTESTINAL RESECTION 1 0.0002
83 NECROSIS 1 0.0002
84 ANGIOPATHY 1 0.0002
85 MICTURITION URGENCY 2 0.0002
86 MOUTH SWELLING 1 0.0002
87 INTENTIONAL OVERDOSE 11 0.0002
88 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
89 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
90 HEPATITIS ACUTE 1 0.0002
91 ANGINA UNSTABLE 1 0.0002
92 SOMNAMBULISM 1 0.0002
93 TACHYPNOEA 2 0.0001
94 ABNORMAL LOSS OF WEIGHT 1 0.0001
95 INFARCTION 1 0.0001
96 AUTOIMMUNE HEPATITIS 1 0.0001
97 HYPOMAGNESAEMIA 2 0.0001
98 RETINAL HAEMORRHAGE 1 0.0001
99 FEELING DRUNK 1 0.0001
100 COLON CANCER 2 0.0001
101 PAROSMIA 1 0.0001
102 GASTROINTESTINAL INFLAMMATION 1 0.0001
103 BLOOD PRESSURE FLUCTUATION 3 0.0001
104 BLOOD POTASSIUM INCREASED 2 0.0001
105 DECUBITUS ULCER 1 0.0001
106 PNEUMONIA ASPIRATION 3 0.0001
107 BLOOD UREA INCREASED 2 0.0001
108 ORTHOSTATIC HYPOTENSION 2 0.0001
109 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
110 HYPERKALAEMIA 4 0.0001
111 GOUT 2 0.0001
112 IRON DEFICIENCY ANAEMIA 1 0.0001
113 ARTERIOSCLEROSIS 1 0.0001
114 SQUAMOUS CELL CARCINOMA 1 0.0001
115 HOT FLUSH 8 0.0001
116 FEELING JITTERY 2 0.0001
117 DIZZINESS POSTURAL 1 0.0001
118 AUTOIMMUNE DISORDER 1 0.0001
119 PHARYNGEAL SWELLING 1 0.0001
120 KNEE OPERATION 1 0.0001
121 SALIVARY HYPERSECRETION 1 0.0001
122 BRAIN INJURY 1 0.0001
123 TOXIC SKIN ERUPTION 1 0.0001
124 PRODUCT ADMINISTRATION ERROR 2 0.0001
125 TASTE DISORDER 2 0.0001
126 EYELID PTOSIS 1 0.0001
127 SLUGGISHNESS 1 0.0001
128 VENTRICULAR EXTRASYSTOLES 1 0.0001
129 RHABDOMYOLYSIS 4 0.0001
130 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
131 BODY HEIGHT DECREASED 1 0.0001
132 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
133 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
134 SEPTIC SHOCK 4 0.0001
135 ACUTE KIDNEY INJURY 14 0.0001
136 WOUND INFECTION 1 0.0001
137 SKIN INFECTION 1 0.0001
138 NEPHROPATHY TOXIC 1 0.0001
139 HYPERLIPIDAEMIA 1 0.0001
140 DIABETIC KETOACIDOSIS 2 0.0001
141 ADRENAL INSUFFICIENCY 1 0.0001
142 HYPERGLYCAEMIA 3 0.0001
143 RESPIRATORY DEPRESSION 1 0.0001
144 TENDON RUPTURE 1 0.0001
145 HYPOTENSION 16 0.0001
146 DERMATITIS ALLERGIC 1 0.0001
147 HIATUS HERNIA 1 0.0001
148 MUCOSAL INFLAMMATION 2 0.0001
149 TOOTH INFECTION 1 0.0001
150 DYSKINESIA 3 0.0001
151 MOOD ALTERED 2 0.0001
152 PERIPHERAL COLDNESS 1 0.0001
153 COMPLETED SUICIDE 6 0.0001
154 HUNGER 1 0.0001
155 HYPONATRAEMIA 4 0.0001
156 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
157 ANOSMIA 1 0.0001
158 SKIN HAEMORRHAGE 1 0.0001
159 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
160 DRUG ADMINISTRATION ERROR 2 0.0001
161 THYROID DISORDER 1 0.0001
162 SENSORY DISTURBANCE 1 0.0001
163 BLOOD CREATININE INCREASED 4 0.0001
164 BLOOD PRESSURE DECREASED 4 0.0001
165 RENAL IMPAIRMENT 5 0.0001
166 TOXICITY TO VARIOUS AGENTS 10 0.0001
167 CANDIDA INFECTION 1 0.0001
168 BLOOD PRESSURE INCREASED 9 0.0001
169 CIRCULATORY COLLAPSE 1 0.0001
170 METASTASES TO LIVER 1 0.0001
171 DRUG INTERACTION 9 0.0001
172 BRADYCARDIA 3 0.0001
173 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
174 RESTLESSNESS 2 0.0001
175 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
176 BACTERIAL INFECTION 1 0.0001
177 HYPERTENSION 11 0.0001
178 ERUCTATION 1 0.0001
179 DYSTONIA 1 0.0001
180 HAEMORRHOIDS 1 0.0001
181 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
182 BLOOD PRESSURE ABNORMAL 1 0.0001
183 PULMONARY HYPERTENSION 1 0.0000
184 CARDIO-RESPIRATORY ARREST 2 0.0000
185 RENAL FAILURE ACUTE 2 0.0000
186 IMPAIRED WORK ABILITY 1 0.0000
187 POOR QUALITY SLEEP 1 0.0000
188 ANGIOEDEMA 2 0.0000
189 RASH MACULO-PAPULAR 1 0.0000
190 ORAL PAIN 1 0.0000
191 GASTROINTESTINAL DISORDER 4 0.0000
192 PRODUCT AVAILABILITY ISSUE 1 0.0000
193 PERICARDIAL EFFUSION 1 0.0000
194 SLEEP DISORDER 3 0.0000
195 PRODUCT PRESCRIBING ERROR 1 0.0000
196 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
197 LIVER INJURY 1 0.0000
198 ENCEPHALOPATHY 1 0.0000
199 AGEUSIA 1 0.0000
200 SYNCOPE 4 0.0000
201 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
202 PRODUCT COMPLAINT 1 0.0000
203 HEPATITIS 1 0.0000
204 PERIPHERAL SWELLING 6 0.0000
205 ERECTILE DYSFUNCTION 1 0.0000
206 ILLNESS 4 0.0000
207 UNRESPONSIVE TO STIMULI 1 0.0000
208 SKIN ULCER 1 0.0000
209 DEAFNESS 1 0.0000
210 PAIN OF SKIN 1 0.0000
211 LIMB INJURY 1 0.0000
212 CARDIAC ARREST 3 0.0000
213 RESPIRATORY ARREST 1 0.0000
214 PROCEDURAL PAIN 1 0.0000
215 FEELING COLD 1 0.0000
216 NECK PAIN 2 0.0000
217 FLATULENCE 2 0.0000
218 HERPES ZOSTER 2 0.0000
219 DYSSTASIA 1 0.0000
220 ACUTE MYOCARDIAL INFARCTION 1 0.0000
221 TACHYCARDIA 3 0.0000
222 HEPATIC FAILURE 1 0.0000
223 CORONARY ARTERY DISEASE 1 0.0000
224 OEDEMA PERIPHERAL 4 0.0000
225 VERTIGO 2 0.0000
226 FEMUR FRACTURE 1 0.0000
227 MOOD SWINGS 1 0.0000
228 MOVEMENT DISORDER 1 0.0000
229 LACTIC ACIDOSIS 1 0.0000
230 ATRIAL FIBRILLATION 3 0.0000
231 STAPHYLOCOCCAL INFECTION 1 0.0000
232 FEBRILE NEUTROPENIA 2 0.0000
233 LIP SWELLING 1 0.0000
234 TYPE 2 DIABETES MELLITUS 1 0.0000
235 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
236 FEELING ABNORMAL 7 0.0000
237 HYPOXIA 1 0.0000
238 MYELOSUPPRESSION 1 0.0000
239 RESPIRATORY FAILURE 2 0.0000
240 AGITATION 2 0.0000
241 DYSURIA 1 0.0000
242 CHEST PAIN 5 0.0000
243 DYSPNOEA EXERTIONAL 1 0.0000
244 MUSCULAR WEAKNESS 3 0.0000
245 COLITIS 1 0.0000
246 PLASMA CELL MYELOMA 1 0.0000
247 DIZZINESS 12 0.0000
248 DIARRHOEA 15 0.0000
249 MENTAL DISORDER 1 0.0000
250 CONSTIPATION 5 0.0000
251 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
252 RENAL FAILURE 3 0.0000
253 DEHYDRATION 3 0.0000
254 THERAPY NON-RESPONDER 1 0.0000
255 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
256 SKIN IRRITATION 1 0.0000
257 TINNITUS 1 0.0000
258 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
259 BLOOD CHOLESTEROL INCREASED 1 0.0000
260 BLOOD GLUCOSE DECREASED 1 0.0000
261 CONTUSION 2 0.0000
262 DRUG INEFFECTIVE 27 0.0000
263 DYSPEPSIA 2 0.0000
264 HEART RATE INCREASED 2 0.0000
265 PRODUCT USE IN UNAPPROVED INDICATION 5 0.0000
266 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
267 ABDOMINAL DISTENSION 2 0.0000
268 PARAESTHESIA 3 0.0000
269 DEPRESSED MOOD 1 0.0000
270 RASH PRURITIC 1 0.0000
271 OEDEMA 1 0.0000
272 DEPENDENCE 1 0.0000
273 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
274 HAEMATOCHEZIA 1 0.0000
275 MEDICATION ERROR 1 0.0000
276 URTICARIA 3 0.0000
277 THROMBOCYTOPENIA 2 0.0000
278 CEREBROVASCULAR ACCIDENT 3 0.0000
279 PRODUCT SUBSTITUTION ISSUE 1 0.0000
280 DECREASED APPETITE 4 0.0000
281 COVID-19 3 0.0000
282 PALPITATIONS 2 0.0000
283 BONE PAIN 1 0.0000
284 CATARACT 1 0.0000
285 EMOTIONAL DISTRESS 2 0.0000
286 THERAPEUTIC RESPONSE DECREASED 1 0.0000
287 STOMATITIS 1 0.0000
288 PLEURAL EFFUSION 1 0.0000
289 ANAEMIA 3 0.0000
290 RHINORRHOEA 1 0.0000
291 AMNESIA 1 0.0000
292 SWELLING FACE 1 0.0000
293 PRODUCT DOSE OMISSION 1 0.0000
294 ALOPECIA 3 0.0000
295 NEOPLASM MALIGNANT 1 0.0000
296 PYREXIA 5 0.0000
297 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
298 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
299 THERAPY INTERRUPTED 1 0.0000
300 PRODUCT DOSE OMISSION ISSUE 4 0.0000
301 WEIGHT INCREASED 3 0.0000
302 ASTHENIA 5 0.0000
303 HALLUCINATION 1 0.0000
304 BACK PAIN 3 0.0000
305 FATIGUE 10 0.0000
306 INJECTION SITE HAEMORRHAGE 1 0.0000
307 CARDIAC FAILURE 1 0.0000
308 THROMBOSIS 1 0.0000
309 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
310 CONFUSIONAL STATE 2 0.0000
311 DRY MOUTH 1 0.0000
312 TREMOR 2 0.0000
313 BALANCE DISORDER 1 0.0000
314 MALAISE 5 0.0000
315 NAUSEA 9 0.0000
316 INSOMNIA 3 0.0000
317 HEADACHE 7 0.0000
318 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
319 ADVERSE EVENT 1 0.0000
320 NASOPHARYNGITIS 2 0.0000
321 HYPERSENSITIVITY 2 0.0000
322 WEIGHT DECREASED 3 0.0000
323 BREAST CANCER 1 0.0000
324 COUGH 3 0.0000
325 CARDIAC DISORDER 1 0.0000
326 PRODUCT USE ISSUE 2 0.0000
327 BLOOD GLUCOSE INCREASED 2 0.0000
328 ANXIETY 3 0.0000
329 SOMNOLENCE 2 0.0000
330 PAIN 6 0.0000
331 CHEST DISCOMFORT 1 0.0000
332 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
333 HAEMOGLOBIN DECREASED 1 0.0000
334 ERYTHEMA 2 0.0000
335 ARTHRALGIA 4 0.0000
336 FALL 3 0.0000
337 INFLUENZA 1 0.0000
338 SEPSIS 1 0.0000
339 SEIZURE 1 0.0000
340 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
341 VOMITING 4 0.0000
342 JOINT SWELLING 1 0.0000
343 VISUAL IMPAIRMENT 1 0.0000
344 LOSS OF CONSCIOUSNESS 1 0.0000
345 PSORIASIS 1 0.0000
346 PRODUCT QUALITY ISSUE 1 0.0000
347 DYSPNOEA 4 0.0000
348 RASH 3 0.0000
349 CONDITION AGGRAVATED 2 0.0000
350 ABDOMINAL DISCOMFORT 1 0.0000
351 URINARY TRACT INFECTION 1 0.0000
352 MYOCARDIAL INFARCTION 1 0.0000
353 NO ADVERSE EVENT 1 0.0000
354 MUSCLE SPASMS 1 0.0000
355 GAIT DISTURBANCE 1 0.0000
356 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
357 ABDOMINAL PAIN UPPER 1 0.0000
358 OVERDOSE 1 0.0000
359 DEPRESSION 1 0.0000
360 INCORRECT DOSE ADMINISTERED 1 0.0000
361 ABDOMINAL PAIN 1 0.0000
362 DEATH 3 0.0000
363 OFF LABEL USE 3 0.0000
364 PAIN IN EXTREMITY 1 0.0000
365 INJECTION SITE PAIN 1 0.0000
366 PNEUMONIA 1 0.0000
367 PRURITUS 1 0.0000